Celtaxsys (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- June 08, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Company Description
- Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is building a sustainable pipeline of first-in-class immuno-modulators, the most advanced of which is CTX-4430.
- Market
- Pharmaceuticals
- Location
- Atlanta, GA, USA
- Coinvestors
- Domain Associates, Georgia Research Alliance, Lumira Capital, Masters Capital Management, RusnanoMedInvest